Albumedix Is Now Part of Sartorius

Empowering Excellence in the Hands of Our Partners

As a science-driven company and recognized leader of best-in-class albumin-enabled solutions, Albumedix enables the development and commercialisation of advanced therapies and next-generation biopharmaceuticals to the benefit of people worldwide.

Albumedix empowers excellence in your applications; combining high-quality, safe & consistent recombinant human albumin products, bespoke service packages tailor-made to enable your success, and innovative technologies.

Sartorius Completes Acquisition of Albumedix

Read Press Release

Explore Albumedix´ Solutions

Recombumin® Recombinant Human Albumin

Find high-quality animal and human-origin-free recombinant human albumins in the Recombumin® product portfolio.

Learn More

Innovation & Compliance Services

Our experts can help increase your likelihood of technical success or navigate complex quality, technical or regulatory challenges.

Learn More

Veltis® Technology

Our proprietary drug delivery platform uses engineered recombinant albumin for optimal therapeutic performance of your API.

Learn More

Albumin Applications

Cell Therapy

Recombumin® products are used in a range of cell therapy media and products offering increased viability, consistency and security.

Learn More

Viral vector-based technologies

Looking to improve stability, dose control, transduction efficiency or production yield? Albumin could be the natural solution.

Learn More

Vaccine Stabilization

Recombumin® products protects vaccines from sheer stress, surface adsorption and provides thermal stability to sensitive vaccines.

Learn More

Protein and Peptide Stabilization

Our products have a long history in the stabilization of proteins and peptides by preventing aggregation, surface adsorption and oxidation.

Learn More

Medical Device Coating

The properties of recombinant human albumins make them the natural, fully biocompatible choice for medical device coatings.

Learn More


They are manufactured at our site in Nottingham, UK from our proprietary Saccharomyces yeast strains, at ICH Q7 cGMP standards. As such it is the highest quality animal origin-free rAlb product commercially available.

Yes – As an example, Recombumin® is already used in two marketed vaccine products; Merck & Co’s MMR®-II and Proquad® childhood vaccine.

Please visit our Recombumin® product page for further product information or to submit an inquiry.


Now Part of Sartorius

In recent years, Sartorius has been continuously making acquisitions, expanding its portfolio by new, complementary technologies.

Explore Recent Acquisitions

Consult Our Experts

Consult Our Experts